Overview
The plaque psoriasis treatment market size addresses a chronic, autoimmune skin condition characterized by red, scaly plaques. As of 2024, approximately 128.64 million people globally were affected by plaque psoriasis—a figure expected to rise to 172.88 million by 2034, growing at a 3.00% CAGR . The expanding patient population and advanced therapies are transforming the...
The Moderate Psoriasis Epidemiology Forecast provides a comprehensive assessment of prevalence, incidence, diagnosed cases, and projected patient growth across major global markets. Moderate psoriasis is a chronic autoimmune skin disorder characterized by red, scaly plaques affecting approximately 3% to 10% of the body surface area (BSA). Commonly affected regions include the arms, legs, scalp,...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt